DYN Overview
Upcoming Projects (DYN)
-
Discussing Avidity's del-desiran as a potential therapy to treat DM1 (Myotonic Dystrophy Type 1)
Tickers: RNA, DYN
Scheduled For: Jan 22, 2025 at 01:00 PM EST
Executed Projects (DYN)
-
Discussing the data from the Phase 1/2 ACHIEVE trial of DYNE-101 in patients with DM1 and the ongoing Phase 1/2 DELIVER trial of DYNE-251 in patients with DMD.
Ticker: DYN
Executed On: Jun 20, 2024 at 02:00 PM EDT -
A Second View: Investigating DYNE-101 and DYNE-251, two therapies being developed by Dyne Therapeutics for the treatment of myotonic dystrophy and DMD.
Ticker: DYN
Executed On: Mar 28, 2024 at 02:00 PM EDT -
Investigating DYNE-101 and DYNE-251, two therapies being developed by Dyne Therapeutics for the treatment of myotonic dystrophy and DMD.
Ticker: DYN
Executed On: Mar 06, 2024 at 05:00 PM EST
Upcoming & Overdue Catalysts (DYN)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (DYN)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
